Previous close | 633.00 |
Open | 657.31 |
Bid | 629.80 x 900 |
Ask | 679.30 x 21500 |
Day's range | 657.31 - 657.31 |
52-week range | 336.03 - 657.31 |
Volume | |
Avg. volume | 162 |
Market cap | 47.403B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 73.12 |
EPS (TTM) | 8.99 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 4.41 (0.70%) |
Ex-dividend date | 13 May 2024 |
1y target est | N/A |
ESLOY vs. LZAGY: Which Stock Is the Better Value Option?
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.